Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
22 Nov 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/biosight-launches-a-phase-12-clinical-trial-of-aspacytarabine-in-combination-with-venetoclax-for-first-line-aml-induction-therapy-followed-by-aspacytarabine-consolidation-301685067.html
22 Sep 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/09/22/2521078/22558/en/BioSig-Launches-PURE-EP-Software-Version-6-with-ACCUVIZ-Module.html
01 Aug 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/biosight-granted-orphan-drug-designation-from-the-fda-for-aspacytarabine-for-the-treatment-of-myelodysplastic-syndromes-301596832.html
06 Jan 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/01/06/2362832/0/en/Biosight-Reports-Final-Primary-Endpoint-Data-from-Phase-2b-Study-of-Aspacytarabine-BST-236-for-First-Line-Acute-Myeloid-Leukemia-Therapy.html
12 Nov 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/11/12/2333405/0/en/Biosight-Announces-Initiation-of-Phase-2-Clinical-Trial-of-Aspacytarabine-for-MDS-and-AML.html
11 Nov 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/11/11/2332600/0/en/Biosight-Encourages-Advaxis-Stockholders-to-Vote-FOR-Proposed-Merger.html
ABOUT THIS PAGE